bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.2754
+0.0503 (22.37%)
May 20, 2025, 1:59 PM - Market open
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $5.03 million as of May 20, 2025. Its market cap has decreased by -82.18% in one year.
Market Cap
5.03M
Enterprise Value
4.99M
1-Year Change
-82.18%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $5.03M, a decrease of -88.83%. That is a compound annual growth rate of -55.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 3.86M | -72.75% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |